QQ客服 官方微博 反馈留言

浏览/检索结果: 共3条，第1-3条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Primary debulking surgery vs. neoadjuvant chemotherapy followed by interval debulking surgery for patients with advanced ovarian cancer. 期刊论文 Arch Gynecol Obstet., 2016, 卷号: Vol.293 No.1, 页码: 163-168 作者:  Bian C;  Yao K;  Li L;  Yi T;  Zhao X. 收藏  |  浏览/下载：3/0  |  提交时间：2019/03/01 Reduction of CA125 Levels During Neoadjuvant Chemotherapy Can Predict Cytoreduction to No Visible Residual Disease in Patients with Advanced Epithelial Ovarian Cancer, Primary Carcinoma of Fallopian tube and Peritoneal Carcinoma 期刊论文 2016, 卷号: 7, 期号: 15, 页码: 2327-2332 作者:  Zeng, Jing;  Yin, Jie;  Song, Xiao;  Jin, Ying;  Li, Yan 收藏  |  浏览/下载：9/0  |  提交时间：2020/01/04 epithelial ovarian cancer  CA125  interval debulking surgery  neoadjuvant chemotherapy   Multiple Cycles of Neoadjuvant Chemotherapy Associated With Poor Survival in Bulky Stage IIIC and IV Ovarian Cancer 期刊论文 INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 卷号: 25, 期号: 8 作者:  Ren, Yulan;  Shi, Tingyan;  Jiang, Rong;  Yin, Sheng;  Wang, Pan 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/13 Ovarian cancer  Neoadjuvant chemotherapy  Primary debulking surgery  Survival